166
Views
25
CrossRef citations to date
0
Altmetric
Brief Definite Report

Leukocyte and platelet activation in patients with giant cell arteritis and polymyalgia rheumatica: A clue to thromboembolic risks?

Brief Definite Report

, , , , &
Pages 386-388 | Received 21 Oct 2008, Accepted 07 Jan 2009, Published online: 13 Aug 2009

References

  • Salvarani C, Cantini F, Hunder GG. Polymyalgia rheumatica and giant cell arteritis. Lancet 2008; 372: 234–245
  • Pryshchep O, Ma-Krupa W, Younge BR, Goronzy JJ, Weyand CM. Vessel-specific Toll-like receptor profiles in human medium and large arteries. Circulation 2008; 118: 1276–1284
  • Manfredi AA, Sabbadini MG, Ferri L, Bianchi ME, Rovere-Querini P. Mechanisms of systemic vasculitis. Drug Discov Today Dis Mech 2004; 1: 297–302
  • Ruegg S, Engelter S, Jeanneret C, Hetzel A, Probst A, Steck AJ, et al. Bilateral vertebral artery occlusion resulting from giant cell arteritis: Report of 3 cases and review of the literature. Medicine 2003; 82: 1–12
  • Salvarani C, Casali B, Farnetti E, Pipitone N, Formisano D, Nicoli D, et al. PlA1/A2 polymorphism of the platelet glycoprotein receptor IIIA and risk of cranial ischemic complications in giant cell arteritis. Arthritis Rheum 2007; 56: 3502–3508
  • Nesher G, Berkun Y, Mates M, Baras M, Rubinow A, Sonnenblick M. Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis. Arthritis Rheum 2004; 50: 1332–1337
  • Lee MS, Smith SD, Galor A, Hoffman GS. Antiplatelet and anticoagulant therapy in patients with giant cell arteritis. Arthritis Rheum 2006; 54: 3306–3309
  • Foell D, Hernandez-Rodriguez J, Sanchez M, Vogl T, Cid MC, Roth J. Early recruitment of phagocytes contributes to the vascular inflammation of giant cell arteritis. J Pathol 2004; 204: 311–316
  • Chatelain D, Duhaut P, Schmidt J, Loire R, Bosshard S, Guernou M, et al. Pathological features of temporal arteries in patients with giant cell arteritis presenting with permanent visual loss. Annals Rheum Dis 2009; 68: 84–88
  • Furie B, Furie BC. Mechanisms of thrombus formation. New Engl J Med 2008; 359: 938–949
  • Maugeri N, Giordano G, Petrilli MP, Fraticelli V, de Gaetano G, Cerletti C, et al. Inhibition of tissue factor expression by hydroxyurea in polymorphonuclear leukocytes from patients with myeloproliferative disorders: A new effect for an old drug?. J Thromb Haemost 2006; 4: 2593–2598
  • Nesher G, Berkun Y, Mates M, Baras M, Nesher R, Rubinow A, et al. Risk factors for cranial ischemic complications in giant cell arteritis. Medicine 2004; 83: 114–122

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.